Very recently, two prevalent and mutually exclusive mutations in the promoter of TERT (228C>T and 250C>T) emerged as the most frequently observed non-coding mutations in cancer and were associated with high levels of telomerase in multiple cancer types [158]. The gene discussed is TERT; the disease is cancer.